Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
The latest announcement is out from China Isotope & Radiation Corp. ( (HK:1763) ).
China Isotope & Radiation Corporation has announced proposed further amendments to its Articles of Association, as well as the Rules of Procedures for both the Shareholders’ General Meeting and the Board. These amendments are in response to updates required by the Company Law of the People’s Republic of China and aim to align with regulatory policies and the company’s current situation. The proposed changes are subject to shareholder approval at the 2024 annual general meeting, and a circular detailing these amendments will be sent to shareholders.
More about China Isotope & Radiation Corp.
China Isotope & Radiation Corporation operates in the nuclear technology industry, focusing on the production and application of isotopes and radiation technologies. The company provides a range of products and services including medical isotopes, radiopharmaceuticals, and radiation processing, catering primarily to healthcare and industrial sectors.
Average Trading Volume: 277,505
Technical Sentiment Signal: Sell
Current Market Cap: HK$3.73B
Learn more about 1763 stock on TipRanks’ Stock Analysis page.
Trending Articles:
- “The No. 1 Destination for the Most Talented Artists”: Netflix Stock (NASDAQ:NFLX) Notches Up as the Duffer Brothers Consider Jumping Ship
- “Breakthrough EVs”: Ford Stock (NYSE:F) Notches Up on New Battery Details
- “An Equity Stake”: Intel Stock (NASDAQ:INTC) Surges as U.S. Government May Buy In With CHIPS Act Money